Filipe Ferreira

Filipe Ferreira

Auto-generated profile, based on publicly available information

Filipe Ferreira

Cell Biology of Viral Infection Lab, Instituto Gulbenkian de Ciência

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMarta Alenquer
Marta Alenquer
SCSílvia Costa
Sílvia Costa
TETemitope Akhigbe Etibor
Temitope Akhigbe Etibor
FFFilipe Ferreira
Filipe Ferreira
ASAna Laura Sousa
Ana Laura Sousa
MAMaria Amorim
Maria Amorim
Influenza A virus has an eight-partite RNA genome that during viral assembly forms a complex containing one copy of each RNA. Genome assembly is a selective process driven by RNA-RNA interactions and is hypothesized to lead to discrete punctate structures scattered through the cytosol. Here, we show that contrary to the accepted view, formation of these structures precedes RNA-RNA interactions among distinct viral ribonucleoproteins (vRNPs), as they assemble in cells expressing only one vRNP type. We demonstrate that these viral inclusions display characteristics of liquid organelles, segregating from the cytosol without a delimitating membrane, dynamically exchanging material and adapting fast to environmental changes. We provide evidence that viral inclusions develop close to endoplasmic reticulum (ER) exit sites, depend on continuous ER-Golgi vesicular cycling and do not promote escape to interferon response. We propose that viral inclusions segregate vRNPs from the cytosol and facilitate selected RNA-RNA interactions in a liquid environment.

1 August 2012 in Current Biology
Verified
Journal Article
Closed access
FFFilipe Ferreira
Filipe Ferreira
MFMatthew Foley
Matthew Foley
ACAlex Cooke
Alex Cooke
MCMargaret Rose Rose Cunningham
Margaret Rose Rose Cunningham
GSGemma Smith
Gemma Smith
ESElizabeth Smythe
Elizabeth Smythe

18 September 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
HMHannes Maib
Hannes Maib
FFFilipe Ferreira
Filipe Ferreira
SVStéphane Vassilopoulos
Stéphane Vassilopoulos
LSLiz Smythe
Liz Smythe
Clathrin light chains (CLCs) control selective uptake of a range of G protein–coupled receptors (GPCRs), although the mechanism by which this occurs has remained elusive thus far. In particular, site-specific phosphorylation of CLCb controls the uptake of the purinergic GPCR P2Y12, but it is dispensable for the constitutive uptake of the transferrin receptor (TfR). We demonstrate that phosphorylation of CLCb is required for the maturation of clathrin-coated pits (CCPs) through the transition of flat lattices into invaginated buds. This transition is dependent on efficient clathrin exchange regulated by CLCb phosphorylation and mediated through auxilin. Strikingly, this rearrangement is required for the uptake of P2Y12 but not TfR. These findings link auxilin-mediated clathrin exchange to early stages of CCP invagination in a cargo-specific manner. This supports a model in which CCPs invaginate with variable modes of curvature depending on the cargo they incorporate.

1 December 2017 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
ARAna Ramos-Nascimento
Ana Ramos-Nascimento
BKBárbara Kellen
Bárbara Kellen
FFFilipe Ferreira
Filipe Ferreira
MAMarta Alenquer
Marta Alenquer
SCSílvia Costa
Sílvia Costa
MAMaria Amorim
Maria Amorim
Influenza A is a rapidly evolving virus that is successful in provoking periodic epidemics and occasional pandemics in humans. Viral assembly is complex as the virus incorporates an eight-partite genome of RNA (in the form of viral ribonucleoproteins, vRNPs), and viral genome assembly − with its implications to public health − is not completely understood. It has previously been reported that vRNPs are transported to the cell surface on Rab11-containing vesicles by using microtubules but, so far, no molecular motor has been assigned to the process. Here, we have identified KIF13A, a member of the kinesin-3 family, as the first molecular motor to efficiently transport vRNP-Rab11 vesicles during infection with influenza A. Depletion of KIF13A resulted in reduced viral titers and less accumulation of vRNPs at the cell surface, without interfering with the levels of other viral proteins at sites of viral assembly. In addition, when overexpressed and following two separate approaches to displace vRNP-Rab11 vesicles, KIF13A increased levels of vRNP at the plasma membrane. Together, our results show that KIF13A plays an important role in the transport of influenza A vRNPs, a crucial step for viral assembly. This article has an associated First Person interview with the first author of the paper.

4 April 2023 in eLife
Verified
Journal Article
Open access
TETemitope Akhigbe Etibor
Temitope Akhigbe Etibor
SCSílvia Costa
Sílvia Costa
SSSindhuja Sridharan
Sindhuja Sridharan
DBDaniela Brás
Daniela Brás
IBIsabelle Becher
Isabelle Becher
MAMaria Amorim
Maria Amorim
In biological systems, liquid and solid-like biomolecular condensates may contain the same molecules but their behaviour, including movement, elasticity, and viscosity, is different on account of distinct physicochemical properties. As such, it is known that phase transitions affect the function of biological condensates and that material properties can be tuned by several factors including temperature, concentration, and valency. It is, however, unclear if some factors are more efficient than others at regulating their behaviour. Viral infections are good systems to address this question as they form condensates de novo as part of their replication programmes. Here, we used influenza A virus (IAV) liquid cytosolic condensates, AKA viral inclusions, to provide a proof of concept that liquid condensate hardening via changes in the valency of its components is more efficient than altering their concentration or the temperature of the cell. Liquid IAV inclusions may be hardened by targeting vRNP (viral ribonucleoprotein) interactions via the known NP (nucleoprotein) oligomerising molecule, nucleozin, both in vitro and in vivo without affecting host proteome abundance nor solubility. This study is a starting point for understanding how to pharmacologically modulate the material properties of IAV inclusions and may offer opportunities for alternative antiviral strategies.

8 September 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
JGJuliana Gonçalves
Juliana Gonçalves
MMMagda Melro
Magda Melro
MAMarta Alenquer
Marta Alenquer
CACatarina Araújo
Catarina Araújo
JCJúlia Castro-Neves
Júlia Castro-Neves
HSHelena Soares
Helena Soares
The intricate interplay between maternal immune response to SARS-CoV-2 and the transfer of protective factors to the fetus remains unclear. By analyzing mother-neonate dyads from second and third trimester SARS-CoV-2 infections, our study shows that neutralizing antibodies (NAbs) are infrequently detected in cord blood. We uncovered that this is due to impaired IgG-NAb placental transfer in symptomatic infection and to the predominance of maternal SARS-CoV-2 NAbs of the IgA and IgM isotypes, which are prevented from crossing the placenta. Crucially, the balance between maternal antiviral response and transplacental transfer of IgG-NAbs appears to hinge on IL-6 and IL-10 produced in response to SARS-CoV-2 infection. In addition, asymptomatic maternal infection was associated with expansion of anti–SARS-CoV-2 IgM and NK cell frequency. Our findings identify a protective role for IgA/IgM-NAbs in gestational SARS-CoV-2 infection and open the possibility that the maternal immune response to SARS-CoV-2 infection might benefit the neonate in 2 ways, first by skewing maternal immune response toward immediate viral clearance, and second by endowing the neonate with protective mechanisms to curtail horizontal viral transmission in the critical postnatal period, via the priming of IgA/IgM-NAbs to be transferred by the breast milk and via NK cell expansion in the neonate.